Consultimab Ltd
11755586
Healthy
- Current liabilities exceed current assets (-10)
Details
Compliance
Last accounts
31/03/2026
dormant
Next accounts due
31/12/2027
Confirmation statement
Last: 07/01/2026
Due 21/01/2027
Industry
Officers
director · Since 08/01/2019
DIRECTOR
FRENCH,BRITISH · UNITED KINGDOM · Age 37
Persons with Significant Control
Ms Esther Marine Daphne Marianne Laisne
French,British · England · Age 37
61, Bridge Street, Kington, HR5 3DJ
Notified 08/01/2019
CompanyRankvs 154255+ SIC 70229 peers34
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/03/2026
Net Worth
£178
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
£178
Working capital
Current Assets
£1
Current Liabilities
£179
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2026 | 0.01 | — |
| 2025 | 0.01 | — |
| 2024 | 0.01 | — |
| 2023 | 0.00 | — |
| 2022 | 31.82 | -£21k |
| 2021 | 157.39 | +£81k |
| 2020 | -20.13 | — |
Derived from filed accounts. Not audited figures.